Radiotherapy-induced cardiotoxicity after the treatment of pulmonary and mediastinal solid tumors

Basit Öğe Kaydı
dc.authoridGörkem Türkkan / 0000-0002-9084-2599en_US
dc.authorscopusidGörkem Türkkan / 56841633300en_US
dc.authorwosidGörkem Türkkan / E-7048-201
dc.contributor.authorSaynak, Mert
dc.contributor.authorTürkkan, Görkem
dc.contributor.authorNurlu, Dilek
dc.contributor.authorOzguven, Yildiray
dc.date.accessioned2022-06-16T12:23:14Z
dc.date.available2022-06-16T12:23:14Z
dc.date.issued2022en_US
dc.departmentİstinye Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractThoracic tumors are extremely common and radiotherapy plays an important role in the treatment of these malignancies. Cardiac radiation exposure which is inevitable during thoracic radiotherapy may damage the heart muscle, valves, or coronary arteries. If a malignant thoracic disease can be successfully treated with the contribution of radiotherapy, long-term cardiac toxicity will become a critical factor in determining survival. Therefore, radiation oncologists have recently focused on efforts to provide local disease control without causing toxicity. Over time, advances in radiotherapy techniques have made it possible to significantly limit the dose of cardiac structures while effectively treating the thoracic tumor. Intensity-modulated radiotherapy techniques are beneficial in reducing the cardiac dose and therefore cardiac toxicity. Advanced particle radiotherapy applications such as proton therapy have the potential to improve tumor cell killing efficiency and reduce the risk of cardiac complications. Close and long-term cooperation between radiation oncologists and cardiologists is important in the follow-up of patients undergoing thoracic radiotherapy. © 2022, Turkish Society for Radiation Oncology.en_US
dc.identifier.citationSaynak, M., Türkkan, G., Nurlu, D., & Özgüven, Y. (2022). Radiotherapy-induced cardiotoxicity after the treatment of pulmonary and mediastinal solid tumors. Turk Onkoloji Dergisi, 37(2), 20-27. doi:10.5505/tjo.2022.S1004en_US
dc.identifier.doi10.5505/tjo.2022.S1004en_US
dc.identifier.endpage27en_US
dc.identifier.issn1300-7467en_US
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85127693657en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage20en_US
dc.identifier.urihttps://doi.org/10.5505/tjo.2022.S1004
dc.identifier.urihttps://hdl.handle.net/20.500.12713/2916
dc.identifier.volume37en_US
dc.identifier.wosWOS:001132582400004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorTürkkan, Görkem
dc.language.isoenen_US
dc.publisherIstanbul Tip Fakultesien_US
dc.relation.ispartofTurk Onkoloji Dergisien_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCardiotoxicityen_US
dc.subjectLung Canceren_US
dc.subjectThoracic Radiotherapyen_US
dc.subjectThoracic Sarcomasen_US
dc.subjectThymic Tumorsen_US
dc.titleRadiotherapy-induced cardiotoxicity after the treatment of pulmonary and mediastinal solid tumorsen_US
dc.typeReview Articleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
pdf_TOD_1321.pdf
Boyut:
342.92 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu